| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. DYN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.28M | $110.10M | - | |
| Dir | 1.16M | $24.19M | - | |
| CEO | 368.2K | $7.68M | -2,683 | |
| Other | 169.2K | $3.53M | -887 | |
| Other | 154.2K | $3.22M | -145 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | Farwell Wildon55 | Chief Medical Officer | Sell | 2,636 | $31.27 | $82,427.72 | -0.9% | +4.9% | -52.9% | |
| Jun 11, 2024 | Beskrovnaya Oxana58 | Chief Scientific Officer | Sell | 2,136 | $31.34 | $66,942.24 | -1.4% | +4.9% | -52.9% | |
| Jun 11, 2024 | McNeill Jonathan55 | Chief Business Officer | Sell | 1,823 | $31.34 | $57,132.82 | -1.3% | +4.9% | -52.9% | |
| Jun 11, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sell | 2,921 | $30.74 | $89,779.24 | -1.3% | +4.9% | -52.9% | |
| Jun 11, 2024 | High Susanna Gatti66 | Chief Operating Officer | Sale+OE | 85,270 | $30.30 | $2,583,782.10 | -15.8% | +4.9% | -52.9% | |
| May 20, 2024 | Beskrovnaya Oxana58 | Chief Scientific Officer | Sale+OE | 30,426 | $32.96 | $1,002,751.23 | -6.2% | +30.4% | -65.1% | |
| May 16, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sell | 2,588 | $28.27 | $73,161.78 | -1.1% | +52.6% | -58.9% | |
| May 16, 2024 | Beskrovnaya Oxana58 | Chief Scientific Officer | Sell | 2,705 | $28.27 | $76,469.37 | -0.9% | +52.6% | -58.9% | |
| May 16, 2024 | Farwell Wildon55 | Chief Medical Officer | Sell | 2,381 | $28.27 | $67,309.95 | -0.8% | +52.6% | -58.9% | |
| May 16, 2024 | High Susanna Gatti66 | Chief Operating Officer | Sell | 2,738 | $28.27 | $77,402.31 | -0.9% | +52.6% | -58.9% |